tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NTLA is currently covered by 19 analysts with an average price target of $22.59. This is a potential upside of $10.94 (93.91%) from yesterday's end of day stock price of $11.65.
Intellia Therapeutics's activity chart (see below) currently has 94 price targets and 125 ratings on display. The stock rating distribution of NTLA is 55.81% BUY, 39.53% HOLD and 4.65% SELL.
Analysts average stock forecasts to be materialized ratio is 43.99% with an average time for these price targets to be met of 123.31 days.
Highest price target for NTLA is $106, Lowest price target is $5, average price target is $22.59.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 06-Oct-2026.
Currently out of the existing stock ratings of NTLA, 24 are a BUY (55.81%), 17 are a HOLD (39.53%), 2 are a SELL (4.65%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 06-Oct-2026
$8
$-3.42 (-29.95%)
16 days ago
(06-Oct-2026)
3/4 (75%)
$-4.37 (-35.33%)
467
Hold Since 01-Jun-2020
$13
$1.58 (13.84%)
1 months 13 days ago
(09-Sep-2026)
11/11 (100%)
$0.79 (6.47%)
262
Buy Since 04-Mar-2021
$30
$18.58 (162.70%)
$30
1 months 13 days ago
(09-Sep-2026)
3/9 (33.33%)
$17.79 (145.70%)
11
Buy Since 28-Jan-2026
$25
$13.58 (118.91%)
$25
1 months 13 days ago
(09-Sep-2026)
0/5 (0%)
$12.79 (104.75%)
Hold Since 02-Mar-2026
$24
$12.58 (110.16%)
$16
2 months 15 days ago
(07-Aug-2026)
1/2 (50%)
$12.06 (101.01%)
51
What is NTLA (Intellia Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on NTLA (Intellia Therapeutics)?
Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?
Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?
Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?
